Hvis patienterne modtager pioglitazon i kombination med et andet sulfonylurinstof end glimepirid, bør patienterne stabiliseres med samtidig indtagelse af pioglitazon og glimepirid, inden de skifter over til Tandemact.
If patients are receiving pioglitazone in combination with a sulphonylurea other than glimepiride, patients should be stabilised with concomitant pioglitazone and glimepiride before switching to Tandemact.